News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA), Clal Biotechnology Industries Raises Stake in Diabetes Treatment Developer, Andromeda; Teva and Clal to Invest $17.5 Million


6/14/2010 6:45:58 AM

Reuters -- Teva Pharmaceutical Industries has exercised an option to raise its stake in Andromeda Biotech, which is developing a treatment for juvenile Type I diabetes, Clal Biotechnology Industries said on Monday.

Read at Reuters
Read at Globes Online
Read at News Release

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES